According to the NCI website, Tagraxofusp is a recombinant protein consisting of human interleukin 3 (IL3) fused to the first 388 amino acids of diphtheria toxin [DT(388)] (DT388IL3) with potential antineoplastic activity. Check for active clinical trials using this agent. (NCI Thesaurus)
- Tazemetostat is used to treat locally advanced and metastatic epithelioid sarcoma.
More Information in English: